Erba Lachema buys Maxmat, a French company - Brno, 21 September 2012
09.10.2012
Erba Lachema has successfully completed its acquisition of Maxmat, a French company operating in the branch of development and manufacturing of medical laboratory devices.
On Friday 21 September Erba Lachema completed the process of acquisition of Maxmat, a French company which develops and manufactures laboratory devices that exploit original patented technologies. Its blood analyzers are used in clinical laboratories not only in Western Europe but also in the USA and other countries.
“For us, Maxmat represents a great potential in the area of development of medical devices, and therefore it is supposed to contribute to additional growth of our company. Moreover, we are sure that its analyzers will soon find customers in our markets. Furthermore, the acquisition offers a highly favourable synergy with the current portfolio of our company. The acquisition of Maxmat is our first acquisition on Western Europe and we strongly believe it is not the last one,” stated Jaroslav Řehůřek, Managing Director of Erba Lachema, in connection with acquisition of the company.
